Ticker League

EBITDA for Medical Properties Trust (MPT) 2004-2026

Latest filings through · Reported

Metric
Profitability

TTM

$947M

YoY change

-136.7%

5Y CAGR

-13.1%

Peak year (FY2022)

$1.67B

EBITDA history chart for Medical Properties Trust (MPT) from 2016 to 2025

Latest: $546M

EBITDA growth chart for Medical Properties Trust (MPT) from 2016 to 2025

Latest: -136.7%

EBITDA history table for Medical Properties Trust (MPT) from 2004 to 2025

  • FY2025$546M-136.7%
  • FY2024-$1.49B-537.4%
  • FY2023$340M-79.7%
  • FY2022$1.67B+14.7%
  • FY2021$1.46B+32.2%
  • FY2020$1.1B+46.5%
  • FY2019$754M+7.3%
  • FY2018$703M+8.6%
  • FY2017$647M+35.9%
  • FY2016$476M+42.5%
  • FY2015$334M+63.4%
  • FY2014$204M+4.5%
  • FY2013$196M+17.3%
  • FY2012$167M+82.1%
  • FY2011$91.5M+44.5%
  • FY2010$63.3M-32.6%
  • FY2009$93.9M+7.3%
  • FY2008$87.5M+27.0%
  • FY2007$68.9M+64.5%
  • FY2006$41.9M+83.6%
  • FY2005$22.8M+214.3%
  • FY2004$7.26M—

EBITDA values are taken from Medical Properties Trust's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Medical Properties Trust (MPT)

According to Medical Properties Trust's latest reported financial statements, the company's current EBITDA (TTM) is $947M. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

Medical Properties Trust (MPT) most recent annual EBITDA stands at $546M (2025) – plunged 136.7% year-over-year.

Over 2020–2025 (5 years), Medical Properties Trust EBITDA expanded at a -13.1% compound annual rate, with a net decline across the window.

Medical Properties Trust EBITDA peaked at $1.67B in 2022; the latest annual figure is $546M in 2025 (67.4% below peak).

The record annual EBITDA stands at $1.67B, reached in 2022; the historical low of -$1.49B was recorded in 2024.

Medical Properties Trust EBITDA by Year

Medical Properties Trust EBITDA 2025: $546M

Medical Properties Trust EBITDA in 2025 was $546M, plunged 136.7% below 2024.

Medical Properties Trust EBITDA 2024: -$1.49B

2024's EBITDA for Medical Properties Trust came in at -$1.49B, plunged 537.4% below 2023. This figure represents the lowest annual value in the available history.

Medical Properties Trust EBITDA 2023: $340M

Medical Properties Trust posted EBITDA of $340M in 2023, plunged 79.7% below 2022.

Medical Properties Trust EBITDA 2022: $1.67B

In 2022, Medical Properties Trust reported EBITDA of $1.67B, grew 14.7% from 2021. This figure represents the highest annual value in the available history.

Medical Properties Trust EBITDA 2021: $1.46B

Medical Properties Trust EBITDA in 2021 was $1.46B.

See more financial history for Medical Properties Trust (MPT).

Sector peers by EBITDA

Real Estate peers of Medical Properties Trust (MPT), ranked by their latest EBITDA

Frequently asked questions

Medical Properties Trust (MPT) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.